Guizhou Utide Biotechnology

China-based GLP-1 peptide API manufacturer and CDMO, headquartered in Zunyi, Guizhou. Says it operates a 20,000 m² cGMP facility with 200+ employees. Specializes in GLP-1 peptide APIs including semaglutide, tirzepatide, retatrutide, and cagrilintide. Holds U.S. DMFs for tirzepatide (DMF 042984) and retatrutide (DMF 043330). Core team has 20+ years of peptide R&D and GMP experience. Also operates as Guizhou MTpeptides Biotechnology Co., Ltd.

Directory assessment: Guizhou Utide Biotechnology is listed as a manufacturer in the peptide supply chain, serving Asia markets from China (Zunyi, Guizhou). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 3 sources for reference. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.